Consensus Repare Therapeutics Inc.

Equities

RPTX

US7602731025

Real-time Estimate Cboe BZX Other stock markets 03:02:33 2024-04-29 pm EDT			5-day change	1st Jan Change
3.175 ^USD	-0.78%		-2.76%	-56.58%

Apr. 26	Repare Therapeutics Inc. Announces Directorate Changes	CI
Feb. 28	Repare Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Evolution of the average Target Price on Repare Therapeutics Inc.

Price target over the last 5 years

History of analyst recommendation changes

69e974144ee87.DIPlqnMfl_DT3L2G5eWOe3aOLFON1wLKmNVxGcfy-Bs.SNyu0hV2oIe-pe_Dtp3kMRj3ez3cszej8btFRqudkEhcz7DpGGXto5mQ9A~2438818fbaaa565c2a5e47f313a373dd

Analyst Recommendations on Repare Therapeutics Inc.

HC Wainwright Adjusts Repare Therapeutics Price Target to $10 From $25, Maintains Buy Rating	Feb. 14	MT
Piper Sandler Cuts Repare Therapeutics' Price Target to $25 From $30, Keeps Overweight Rating	23-10-16	MT
Stifel Raises Repare Therapeutics' Price Target to $17 From $16, Keeps Buy Rating	23-09-25	MT
HC Wainwright Adjusts Price Target on Repare Therapeutics to $25 From $26, Keeps Buy Rating	23-08-17	MT
Stifel Upgrades Repare Therapeutics to Buy From Hold, Adjusts Price Target to $16 From $11	23-06-09	MT
HC Wainwright Adjusts Repare Therapeutics Price Target to $26 From $25, Maintains Buy Rating	23-06-09	MT
Morgan Stanley Adjusts Price Target on Repare Therapeutics to $14 From $15, Maintains Equal-Weight Rating	23-02-27	MT
Morgan Stanley Downgrades Repare Therapeutics to Equal Weight From Overweight, Adjusts Price Target to $15 From $28	23-02-03	MT
HC Wainwright Adjusts Repare Therapeutics' Price Target to $25 From $38, Keeps Buy Rating	22-11-17	MT
Morgan Stanley Adjusts Price Target on Repare Therapeutics to $28 From $30, Maintains Overweight Rating	22-08-08	MT
Berenberg Bank Adjusts Repare Therapeutics' Price Target to $31 From $34, Maintains Buy Rating	22-08-08	MT
Goldman Sachs Adjusts Price Target for Repare Therapeutics to $29 From $30, Maintains Buy Rating	22-08-05	MT
HC Wainwright Adjusts Repare Therapeutics' Price Target to $38 From $54, Keeps Buy Rating	22-06-06	MT
Piper Sandler Adjusts Repare Therapeutics' Price Target to $30 From $25, Keeps Overweight Rating	22-06-02	MT
Berenberg Bank USA Conference	22-05-22	FA
Berenberg Bank Adjusts Repare Therapeutics' Price Target to $34 From $51, Maintains Buy Rating	22-05-12	MT
Stifel Nicolaus Downgrades Repare Therapeutics to Hold From Buy, Adjusts Price Target to $11 From $45	22-04-12	MT
Piper Sandler Adjusts Price Target on Repare Therapeutics to $25 From $40, Reiterates Overweight Rating	22-04-12	MT
Northland Adjusts Repare Therapeutics' Price Target to $45 From $40, Keeps Outperform Rating	21-11-18	MT
REPARE THERAPEUTICS : Stifel Starts Repare Therapeutics at Buy With $48 Price Target	21-09-23	MT
REPARE THERAPEUTICS : HC Wainwright Starts Repare Therapeutics at Buy With $54 Price Target	21-09-13	MT
REPARE THERAPEUTICS : Morgan Stanley Adjusts Price Target on Repare Therapeutics to $47 From $45, Maintains Overweight Rating	21-08-16	MT
REPARE THERAPEUTICS : Guggenheim Starts Repare Therapeutics at Buy With $46 Price Target	21-06-28	MT
REPARE THERAPEUTICS : Berenberg Starts Repare Therapeutics at Buy with $51 Price Target	21-03-01	MT
REPARE THERAPEUTICS : Northland Adjusts Repare Therapeutics' Price Target to $42 From $38, Keeps Outperform Rating	20-12-29	MT